These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8808265)

  • 1. [II. multidisciplinary analysis of chronic excretors of Mycobacterium tuberculosis bacilli].
    Kondo A; Sakatani M; Tsuchiya T; Ogata H; Fujiwara H; Hara H; Yoneda T; Sato K
    Kekkaku; 1996 Jan; 71(1):25-9. PubMed ID: 8808265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiologic study of the actual investigation of chronic excretors of Mycobacterium tuberculosis bacilli].
    Tsuchiya T; Kondo A; Sakatani M
    Kekkaku; 1996 Jan; 71(1):31-6. PubMed ID: 8808266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From the immunological aspect--interleukin-10 production by human blood mononuclear cells stimulated with multidrug-resistant Mycobacterium tuberculosis].
    Fujiwara H; Aotani T; Tsuyuguchi I
    Kekkaku; 1996 Jan; 71(1):43-6. PubMed ID: 8808268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of chronic excretors of Mycobacterium bacilli in Aichi Prefecture].
    Katou M; Kakihara H
    Kekkaku; 1992 Apr; 67(4):331-46. PubMed ID: 1602726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of INH and RFP-resistant refractory tuberculosis].
    Kekkaku; 1991 Oct; 66(10):687-706. PubMed ID: 1960917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exogenous re-infection in tuberculosis].
    Tsuchiya T
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Manegement and countermeasures against tuberculous patients with chronic positive sputum].
    Sato K
    Kekkaku; 1996 Jan; 71(1):65-9. PubMed ID: 8808271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
    Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
    Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB/RIF in Wuhan, China: A Retrospective Study.
    Huang H; Zhang Y; Li S; Wang J; Chen J; Pan Z; Gan H
    Microb Drug Resist; 2018 Jun; 24(5):675-679. PubMed ID: 29053085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-year trend of chronic excretors of tubercle bacilli based on the nationwide tuberculosis prevalence surveys in Korea, 1975-1995.
    Hong YP; Kim SJ; Bai JY; Lew WJ; Lee EG
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):911-9. PubMed ID: 11055757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the characteristics of Mycobacterium tuberculosis isolates from sputum and lung lesions in chronic tuberculosis patients.
    Hong MS; Kim Y; Cho EJ; Lee JS; Kwak HK; Kim JH; Kim CT; Cho JS; Park SK; Jeon D; Choi YI; Lee H; Eum SY
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2063-2072. PubMed ID: 28620844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.